MercadoLibre Brazil Drug Marketplace Faces Regulator Review
The company's plan to launch an online pharmacy marketplace in the country is under review by national health authorities.
This story has stopped developing; this page is its permanent record. More from that day
The odds
Each tick is a source publishing on this story
Price data
| Time | Chance of yes |
|---|---|
| now | 4% |
| 29 Sept, 17:00 UTC | 4% |
The story so far
1 publisher has covered this in 1 article since 30 Sept 2026. Bloomberg Technology published first, on 30 September at 17:22 UTC.
One prediction market prices this story:
- Above 3.6 billion — the market puts it at 4%, closing 31 Mar 2028. The market resolves to Yes if MercadoLibre Inc. reports selling more than 3.6 billion items in 2026. Otherwise, it resolves to No. Readers often mistake the linked news story about a regulatory review for the actual sales data required for resolution.
Odds are the market's probability that the outcome happens, updated every few minutes. They are information about what traders expect, not a forecast we make and not investment advice.
Sources
Every article we clustered into this story. Headlines link to the publisher.
Markets on this story
- Kalshi Above 3.6 billion 4%
Does the market have this right?
Wrong market?
Have your say
Your call. How does this end?
Free, no money involved. Calls are scored against the market's price when you make them, so backing an underdog that wins scores most. Leaderboard · Your calls
Email me when the odds move
In this story
- MercadoLibre
- Brazil